Pages that link to "Q48463843"
Jump to navigation
Jump to search
The following pages link to N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits (Q48463843):
Displayed 48 items.
- Using animal models to determine the significance of complement activation in Alzheimer's disease (Q24796236) (← links)
- An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice (Q30316057) (← links)
- Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions (Q30320504) (← links)
- Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model (Q30478167) (← links)
- Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model (Q30489966) (← links)
- Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease (Q30512697) (← links)
- NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). (Q30666112) (← links)
- Systemic amyloid deposits in familial British dementia. (Q30718374) (← links)
- Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies (Q33747695) (← links)
- Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease (Q33971351) (← links)
- Chromosome 13 dementia syndromes as models of neurodegeneration (Q34109391) (← links)
- Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: Relevance for immunotherapy (Q34348316) (← links)
- Down syndrome and Alzheimer's disease: a link between development and aging (Q34366691) (← links)
- Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice (Q34575806) (← links)
- Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins (Q34750660) (← links)
- Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease. (Q34824216) (← links)
- Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease (Q34988301) (← links)
- Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody (Q35151492) (← links)
- Neurodegeneration caused by proteins with an aberrant carboxyl-terminus (Q35871644) (← links)
- Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein (Q36881483) (← links)
- Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits (Q37301151) (← links)
- Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases (Q37461136) (← links)
- Review: sporadic cerebral amyloid angiopathy (Q37800132) (← links)
- Biology and pathophysiology of the amyloid precursor protein (Q37869935) (← links)
- The amyloid state of proteins in human diseases (Q37994283) (← links)
- From soluble aβ to progressive aβ aggregation: could prion-like templated misfolding play a role? (Q38099070) (← links)
- Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy (Q38176899) (← links)
- Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease. (Q38608487) (← links)
- Implications of peptide assemblies in amyloid diseases (Q39431937) (← links)
- Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation (Q40741905) (← links)
- Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease (Q41971448) (← links)
- Role of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry (Q42375852) (← links)
- Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing (Q42874924) (← links)
- Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival (Q44158602) (← links)
- Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease (Q44363055) (← links)
- Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques. (Q44496212) (← links)
- Evidence for D-aspartyl-beta-amyloid secretase activity in human brain (Q45713208) (← links)
- APP/Aβ structural diversity and Alzheimer's disease pathogenesis (Q46320596) (← links)
- Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques (Q46642854) (← links)
- Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease (Q47133483) (← links)
- Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study (Q47240327) (← links)
- Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42. (Q48104077) (← links)
- Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease (Q48112174) (← links)
- Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease (Q48464739) (← links)
- pH-Dependent Amyloid and Protofibril Formation by the ABri Peptide of Familial British Dementia (Q54126071) (← links)
- Modified amyloid variants in pathological subgroups of β-amyloidosis (Q90224665) (← links)
- Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1 (Q90356091) (← links)
- Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models (Q98163701) (← links)